Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript

Page 4 of 4

Sravan Emany: And Mike do you want to kind of take this?

Mike Shetzline: Yes. I mean yes it’s a fair question and we do get questions on it as well on our side. I mean because as you know I mean the GLP-1s are definitely being heavily used. And it’s also true that obese patients also suffer from constipation quite regularly too. So there is a lot of [indiscernible] use. I mean the actual impact so that you really want to get at it’s hard to nail that down at present, but we certainly appreciate the question. There may be some things there. And we’re looking into it but we don’t really have a direction right now to how to impact that.

Tim Chiang: Okay. Great. Thanks.

Operator: Thank you for your question. And ladies and gentlemen that will conclude today’s Ironwood Pharmaceuticals Q3 2023 investor update conference call. Thank you all for joining. You may now disconnect.

Follow Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

Page 4 of 4